Deca-Durabolin & Equipoise cause Thick Blood – But is it Dangerous?

A physician introduces a common concern about thick blood during anabolic steroid use. Deca Durabolin, Equipoise, and testosterone are named as drugs that raise red blood cells. The talk separates normal erythropoiesis from the diagnosis called polycythemia. Hypoxemia is explained as the classic driver for erythropoietin release from the kidney. Erythropoietin is described as signaling red bone marrow to produce additional red cells. Androgen exposure is presented as another pathway that can push red cell production upward. Several mechanisms are offered, including kidney stimulation, marrow receptor activation, and worsening sleep apnea.

Attention shifts to hemoglobin and hematocrit numbers and how laboratories set reference ranges. Different labs may label the same value as normal or high, creating confusion for patients. A hematocrit around fifty percent is described as common among men receiving testosterone. The question becomes whether slightly elevated numbers represent true dangerous polycythemia. Primary disease states like polycythemia vera are contrasted with secondary androgen mediated states. Three theoretical dangers are reviewed, including viscosity related stroke risk, iron overload effects, and hypercoagulable events. The transcript emphasizes limited data and urges conservative individualized medical judgment.

Management recommendations start with careful history, physical examination, and family risk review. Genetic sensitivity is discussed, including carrier states for hereditary hemochromatosis in some men. Sleep apnea evaluation is emphasized, because treating hypoxemia can lower hematocrit meaningfully. Regular monitoring of CBC and iron studies is encouraged to track trends and avoid surprises. A safe zone is suggested under roughly seventeen point six hemoglobin and under fifty two percent hematocrit. Dose reduction, avoiding unnecessary steroid stacking, and addressing classic cardiovascular risks are repeatedly advised. Phlebotomy is presented as a tool, but over phlebotomizing can create anemia and new problems.